Barclays PLC Cidara Therapeutics, Inc. Transaction History

Barclays PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.43 - $0.91 $1,393 - $2,948	-3,240 Reduced 6.83%	44,185 $22,000
Q4 2021 Feb 14, 2022	SELL	$1.18 - $2.18 $5,789 - $10,695	-4,906 Reduced 9.37%	47,425 $60,000
Q3 2021 Nov 09, 2021	BUY	$1.48 - $2.35 $1,346 - $2,138	910 Added 1.77%	52,331 $117,000
Q2 2021 Aug 13, 2021	SELL	$1.87 - $2.7 $1,288 - $1,860	-689 Reduced 1.32%	51,421 $104,000
Q1 2021 May 13, 2021	BUY	$2.06 - $3.01 $83,386 - $121,841	40,479 Added 348.03%	52,110 $138,000

Q4 2020 Feb 11, 2021	SELL	$1.99 - $3.25 $8,686 - $14,186	-4,365 Reduced 27.29%	11,631 $23,000
Q3 2020 Nov 12, 2020	SELL	$2.85 - $4.1 $6,549 - $9,421	-2,298 Reduced 12.56%	15,996 $46,000
Q2 2020 Aug 12, 2020	BUY	$2.39 - $4.0 $43,722 - $73,176	18,294 New	18,294 $68,000
Q4 2019 Feb 10, 2020	SELL	$1.77 - $3.84 $177 - $384	-100 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.25 - $2.35 $125 - $235	100 New	100 $0
Q2 2018 Aug 14, 2018	SELL	$3.75 - $6.05 $1,125 - $1,815	-300 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$4.0 - $8.15 $49,200 - $100,245	-12,300 Reduced 97.62%	300 $1,000
Q4 2017 Feb 14, 2018	BUY	$6.35 - $8.75 $20,320 - $28,000	3,200 Added 34.04%	12,600 $86,000
Q3 2017 Nov 14, 2017	BUY	$5.75 - $8.1 $54,050 - $76,140	9,400	9,400 $76,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $837M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.